Your Article Summary
See Latest ArticlesThe ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease
International Journal of Geriatric Psychiatry, 06/30/09
A 4-point ADAS-cog change at 6 months is clinically meaningful for groups. Substantial individual misclassification between the ADAS-cog and clinical measures suggests no inherent meaning to a 4-point ADAS-cog change for a given patient.
Methods- Secondary analysis of the video imaging synthesis of treating Alzheimer's disease (VISTA) study: a 4-month, multi-centre, parallel-group, double-blind, placebo-controlled, trial of galantamine in 130 mild-moderate Alzheimer's disease patients (4-month open-label follow-up).
- ADAS-cog responses at 6 months were compared with outcomes on three clinical measures: clinician's interview based impression of change-plus caregiver input (CIBIC+), patient/carer-goal attainment scaling (PGAS) and clinician-GAS (CGAS).
- Thirty-seven of 99 patients improved by 4 points on the ADAS-cog at 6 months, and 16/99 showed 4-point worsening.
- ADAS-cog change scores correlated notionally to modestly with changes on the CGAS (r = -0.31), the PGAS (r = -0.29) and the CIBIC+ (r = 0.31).
- As a group, patients with ADAS-cog improvement were significantly more likely to improve on the clinical measures; those who worsened showed non-significant clinical decline.
- Individually, about half were misclassified in relation to each clinical measure; often when the ADAS-Cog detected no change, clinically meaningful effects could be detected. Even so, no ADAS-Cog cut-point optimally classified patients' clinical responses.
Related Articles
Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09
Relevance Score: 70%
Activated astrocytes: a therapeutic target in Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09
Relevance Score: 69%
High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09
Relevance Score: 69%
New neuroimaging analysis technique identifies impact of Alzheimer's disease gene in healthy brains
EurekAlert, 11/18/09
Relevance Score: 68%
Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09
Relevance Score: 68%
Today in Child/Adolescent Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Screening for Depression and Anxiety in Adolescent Cancer Patients
Journal of Pediatric Hematology/Oncology, 11/30/09
Depression, anxiety and obsessive–compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment
Journal of Psychopharmacology, 11/30/09
Imitation in fragile X syndrome: Implications for autism
Autism, 11/29/09